SCHEMBL1800530

SCHEMBL1800530

CC(C)(C)OC(=O)c1c(-c2ccccc2)csc1NC(=O)CCCCC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
RAB9A P51151 1/20 0.52
ALDH1A1 P00352 8/20 0.48
TP53 P04637 1/20 0.47
LMNA P02545 7/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GSTO1 P78417 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
HIF1A Q16665 1/20 0.43
HTT P42858 2/20 0.43
ALOX12 P18054 1/20 0.43
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799358 0.88 RAB9A (0.62) POLBRAB9AALDH1A1LMNASMN1; SMN2
SCHEMBL1800214 0.87 RAB9A (0.56) POLBRAB9AALDH1A1LMNASMN1; SMN2
SCHEMBL1798657 0.86 RAB9A (0.48) POLBRAB9AALDH1A1TP53LMNA
SCHEMBL1796451 0.86 ANO1 (0.57) POLBALDH1A1MEN1KMT2AHDAC3
SCHEMBL1796957 0.86 RAB9A (0.47) POLBRAB9AALDH1A1TP53LMNA
SCHEMBL1796283 0.86 RAB9A (0.47) POLBRAB9AALDH1A1TP53LMNA
SCHEMBL1954228 0.85 RAB9A (0.52) POLBRAB9AALDH1A1TP53LMNA
SCHEMBL1796954 0.84 POLB (0.46) POLBRAB9AALDH1A1TP53LMNA
SCHEMBL1796259 0.83 RAB9A (0.52) POLBRAB9AALDH1A1LMNASMN1; SMN2
SCHEMBL1799695 0.82 RAB9A (0.51) POLBRAB9AALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 POLB 2674/4885RAB9A 2391/4885ALDH1A1 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.